Viewing Study NCT03207958


Ignite Creation Date: 2025-12-25 @ 12:19 AM
Ignite Modification Date: 2026-01-04 @ 11:21 PM
Study NCT ID: NCT03207958
Status: COMPLETED
Last Update Posted: 2024-03-13
First Post: 2017-06-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Belimumab for Prevention of Chronic Graft-versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation
Sponsor: Washington University School of Medicine
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module